Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Markets up: The S & P … Read more
Nicolai Tangen, chief executive officer of Norges Bank Investment Management, during a news conference in Oslo, Norway, on Tuesday, Jan. 30, 2024. Bloomberg | Bloomberg | Getty Images The chief executive of the world’s largest wealth fund says there are many wild cards in financial markets right now, but the “big worry” for investors is … Read more
CNBC Investing Club with Jim Cramer Rob Kim | NBCUniversal CNBC’s Jim Cramer noted positive stock performances in the market rebound on Monday, but indicated Big Tech earnings coming this week will tell the tale on whether it will last. The Dow Jones Industrial Average climbed 253.58 points, or 0.67%, to close at 38,239.98. The S&P 500 traded 0.87% … Read more
At law school, we learned about “proximate cause,” one of the few valuable concepts you can take from three years of drudgery. It’s about who and what caused the injury and who pays for it. The current stock market lends itself to proximate causes, as in, “We have to find a cause for the pronounced … Read more
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. Both the S & P 500 index and the Nasdaq Composite fell Friday and were on pace for their sixth consecutive negative days. The Dow Jones Industrial was up slightly, … Read more
Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving investors more confidence to keep owning the world’s most valuable health-care company even after it’s been crushing the S & P 500’s performance over the past three years. The study results released by Eli Lilly on Wednesday highlight the … Read more
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Markets wobbly: After a weak attempt … Read more
Off-price is not going off-trend anytime soon. That might not be clear based on recent trading in TJX Companies’ stock. Club holding TJX Companies and rival Ross Stores are well-positioned to keep stealing market share from other retailers, particularly department stores, UBS said in a recent note, keeping a years-long trend in the industry alive. … Read more
Sales of some Eli Lilly drugs — including its best-selling product last year — appear to be softening, according to Wall Street analysts. But that might not be enough to stop its stock from climbing higher. Prescription data for multiple Eli Lilly drugs — especially type-2 diabetes treatment Trulicity — points to weaker trends in … Read more
What a difference a year makes. Club holding Wells Fargo will post quarterly results on Friday, followed by our other financial holding, Morgan Stanley, on Tuesday. The industry’s first-quarter results will come against a more pleasant backdrop than last year, when the March 2023 collapse of Silicon Valley Bank sent shockwaves throughout the sector. The … Read more
